Abiopharma

🔍 Eberwein Jeffrey E. (Director)

Company: STAR EQUITY HOLDINGS, INC. (STRR)

Report Date: 2025-08-22

Detailed Transactions and Holdings:

• Sold 820,374 shares of Common Stock (Direct)
  Date: 2025-08-22 | Code: D | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F1
• Sold 1,182,414 shares of 10% Series A Cumulative Perpetual Preferred Stock (Direct)
  Date: 2025-08-22 | Code: D | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F1
• Sold 2,935 shares of Restricted Stock Unit (Derivative)
  Date: 2025-08-22 | Code: D | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F2, F2, F3, F3
• Sold 3,221 shares of Restricted Stock Unit (Derivative)
  Date: 2025-08-22 | Code: D | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F2, F2, F4, F4
• Sold 860 shares of Restricted Stock Unit (Derivative)
  Date: 2025-08-22 | Code: D | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F5, F5, F6, F6
• Sold 860 shares of Restricted Stock Unit (Derivative)
  Date: 2025-08-22 | Code: D | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F5, F5, F7, F7

Footnotes:

• F1: Disposed of pursuant to the Agreement and Plan of Merger, dated as of May 21, 2025 (the "Merger Agreement"), by and among Star Equity Holdings, Inc. ("Star"), Hudson Global, Inc. ("Hudson") and HSON Merger Sub, Inc., a wholly owned subsidiary of Hudson ("Merger Sub"), in exchange for .23 shares of Hudson common stock for each share of Star common stock on the effective date of the merger (the "Merger") and one share of Hudson Series A Preferred Stock for each share of Star 10% Series A Cumulative Perpetual Preferred Stock on the effective date of the Merger.
• F2: These Restricted Stock Units each represent the right to receive, at settlement, one share of Star common stock. These Restricted Stock Units were assumed by Hudson in the Merger and exchanged for .23 Hudson Restricted Stock Units for each Star Restricted Stock Unit.
• F3: The Restricted Stock Units granted on November 22, 2024 (the "Grant Date") are scheduled to vest upon the first anniversary of the Grant Date.
• F4: The Restricted Stock Units granted on March 25, 2025 (the "Second Grant Date") are scheduled to vest upon the first anniversary of the Second Grant Date.
• F5: These Restricted Stock Units each represent the right to receive, at settlement, one share of Star 10% Series A Cumulative Perpetual Preferred Stock. These Restricted Stock Units were assumed by Hudson in the Merger and exchanged for one Hudson Restricted Stock Unit for each Star Restricted Stock Unit.
• F6: The Restricted Stock Units granted on May 19, 2025 (the "Preferred Grant Date") are scheduled to vest upon the first anniversary of the Preferred Grant Date.
• F7: The Restricted Stock Units granted on August 18, 2025 (the "Second Preferred Grant Date") are scheduled to vest upon the first anniversary of the Second Preferred Grant Date.